(Q34733071)

4 August 2017

0 references

Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis (English)

1 reference

4 August 2017

1 reference

1 reference

1 reference

Zhi Peng

1

1 reference

4 August 2017

Qianqian Wang

2

1 reference

4 August 2017

Jing Gao

3

1 reference

4 August 2017

Zhaoning Ji

4

1 reference

4 August 2017

Jiajia Yuan

5

1 reference

4 August 2017

Ye Tian

6

1 reference

4 August 2017

Lin Shen

7

1 reference

4 August 2017

publication date

22 May 2013

1 reference

Cancer Chemotherapy and Pharmacology

4 August 2017

published in

1 reference

4 August 2017

volume

72

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

305-314

1 reference

Oxaliplatin: a review of preclinical and clinical studies.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Oxaliplatin: a review of approved uses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Management of advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Oxaliplatin-induced neuropathy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

21 January 2018

Glutathione transferases

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Glutathione S-transferases: an overview in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Glutathione S-transferase polymorphisms: cancer incidence and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

The many faces of glutathione transferase pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Associations between glutathione S-transferase pi Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

The role of glutathione-S-transferase in anti-cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2194-X

10.1007/S00280-013-2194-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1009915099

0 references

1 reference